<?xml version='1.0' encoding='utf-8'?>
<document id="21766379"><sentence text="Quantification of the transporter substrate fexofenadine in cell lysates by liquid chromatography/tandem mass spectrometry."><entity charOffset="44-56" id="DDI-PubMed.21766379.s1.e0" text="fexofenadine" /></sentence><sentence text="Drug-drug interactions at transporters present a significant and under-investigated clinical problem" /><sentence text=" Investigations of specific transporter functions and screening for potential drug-drug interactions, both in vitro and especially in vivo, will require validated experimental probes" /><sentence text=" Fexofenadine, an approved, well-tolerated drug, is a promising probe for studies of membrane transporter function"><entity charOffset="1-13" id="DDI-PubMed.21766379.s4.e0" text="Fexofenadine" /></sentence><sentence text=" Although fexofenadine pharmacokinetics are known to be controlled by transporters, the contributions of individual transporters have not been defined"><entity charOffset="10-22" id="DDI-PubMed.21766379.s5.e0" text="fexofenadine" /></sentence><sentence text=" We have developed a rapid, specific, and sensitive analytical method for quantitation of fexofenadine to support this work"><entity charOffset="90-102" id="DDI-PubMed.21766379.s6.e0" text="fexofenadine" /></sentence><sentence text=" This liquid chromatography/tandem mass spectrometry (LC/MS/MS) method quantifies fexofenadine in cell lysates from in vitro studies using cetirizine as the internal standard"><entity charOffset="82-94" id="DDI-PubMed.21766379.s7.e0" text="fexofenadine" /><entity charOffset="139-149" id="DDI-PubMed.21766379.s7.e1" text="cetirizine" /><pair ddi="false" e1="DDI-PubMed.21766379.s7.e0" e2="DDI-PubMed.21766379.s7.e0" /><pair ddi="false" e1="DDI-PubMed.21766379.s7.e0" e2="DDI-PubMed.21766379.s7.e1" /></sentence><sentence text=" Cell lysates were prepared for analysis by acetonitrile precipitation"><entity charOffset="44-56" id="DDI-PubMed.21766379.s8.e0" text="acetonitrile" /></sentence><sentence text=" Analytes were then separated by gradient reversed-phase chromatography and analyzed by tandem mass spectrometry using the m/z 502" /><sentence text="17/466" /><sentence text="2 transition for fexofenadine and m/z 389"><entity charOffset="17-29" id="DDI-PubMed.21766379.s11.e0" text="fexofenadine" /></sentence><sentence text="02/201" /><sentence text="1 for cetirizine"><entity charOffset="6-16" id="DDI-PubMed.21766379.s13.e0" text="cetirizine" /></sentence><sentence text=" The method exhibited a linear dynamic range of 1-500 ng/mL for fexofenadine in cell lysates"><entity charOffset="64-76" id="DDI-PubMed.21766379.s14.e0" text="fexofenadine" /></sentence><sentence text=" The lower limit of quantification was 1 ng/mL with a relative standard deviation of less than 5%" /><sentence text=" Intra- and inter-day precision and accuracy were within the limits presented in the FDA guidelines for bioanalysis" /><sentence text=" We also will validate this method to support not only the quantification of fexofenadine, but also other probe drugs for drug-drug interaction studies"><entity charOffset="77-89" id="DDI-PubMed.21766379.s17.e0" text="fexofenadine" /></sentence><sentence text=" This method for quantification will facilitate the use of fexofenadine as a probe drug for characterization of transporter activity"><entity charOffset="59-71" id="DDI-PubMed.21766379.s18.e0" text="fexofenadine" /></sentence><sentence text="" /></document>